Subscribe for $2

Subscribe for 2 $

Financial Data API

Terminal Financial Data API

CRISPR Therapeutics Aktie News & Pressemeldungen

CRISPR Therapeutics Eulerpool News

12/22/2024, 11:19:51 AM

Vertex Pharmaceuticals: Von Höhenflügen und Herausforderungen im Biotech-Sektor

12/13/2024, 4:27:47 AM

Editas Medicine plant drastische Umstrukturierung und fokussiert auf In-vivo Gentherapien

11/16/2024, 5:59:24 PM

Biotechnologie auf dem Vormarsch: Wachstumschancen bei CRISPR Therapeutics und Iovance Biotherapeutics

11/16/2024, 4:51:29 PM

Gen-Schmiede der Zukunft: CRISPR Therapeutics und Iovance auf Wachstumskurs

10/8/2024, 3:50:13 PM

Wachstumsetfs im Fokus: Chancen und Herausforderungen auf dem Weg zur Rendite

1

2

1

2

CRISPR Therapeutics Stock News

CRISPR Therapeutics is being monitored by journalists and investors worldwide. We gather the latest CRISPR Therapeutics news here.

February 13 ·
SeekingAlpha
Crispr Therapeutics Q4 Earnings Review: Ignore The Lack Of Revenues, Buy The Future
February 5 ·
SeekingAlpha
CRISPR Therapeutics AG (CRSP) Guggenheim SMID Cap Biotech Conference (Transcript)
February 5 ·
SeekingAlpha
Crispr Therapeutics: Why I've Become Even More Bullish (Rating Upgrade)
January 25 ·
SeekingAlpha
Undercovered Dozen: Virgin Galactic, Gold Fields, Matador Resources, EHang +
January 17 ·
SeekingAlpha
Editas And Intellia: Strategic Shifts And Long-Term Investment Potential
January 15 ·
SeekingAlpha
CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers
January 9 ·
Yahoo
3 Mid-Cap Stocks That Could Take Off in 2025
January 8 ·
Yahoo
CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 8 ·
SeekingAlpha
2024 Performance Review And Future Strategy
January 8 ·
Yahoo
CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note

1

2

1

2

CRISPR Therapeutics Stock Press Releases

CRISPR Therapeutics regularly publishes news on the company's website that are relevant for investors.

Access the world's leading financial data and tools

Subscribe for $2